Biotechnology Regulatory Framework in India: Acts, Rules, and Oversight Bodies

The biotechnology regulatory framework in India is a multi-tiered mechanism designed to oversee research, development, environmental release, and commercial application of genetically modified organisms (GMOs) and living modified organisms (LMOs). The primary objective is to balance technological innovation with human health, animal safety, and environmental protection. This governance structure operates under specific acts, legislative rules, and institutional bodies across multiple central ministries.

Primary Legislative and Regulatory Framework

The parent statutory authority governing biotechnology and GMOs in India is the Environment (Protection) Act, 1986 (EPA). Specific operational mandates are derived from regulations framed under this parent legislation and supported by international treaties.

Key Acts and Rules

• Environment (Protection) Act, 1986: Serves as the primary umbrella act for biosafety regulations in the country.
• Rules, 1989: Formally known as the Rules for the Manufacture, Use, Import, Export, and Storage of Hazardous Microorganisms/Genetically Engineered Organisms or Cells, 1989. These rules outline statutory procedures for research, large-scale deployment, and environmental release of GMOs.
• Biological Diversity Act, 2002: Regulates access to biological resources, protection of traditional knowledge, and equitable sharing of benefits arising from genetic resource utilization.
• Food Safety and Standards Act, 2006: Governs the regulation of genetically modified food products through the Food Safety and Standards Authority of India (FSSAI).
• Drugs and Cosmetics Act, 1940: Regulates biopharmaceuticals, recombinant vaccines, and gene-therapy products through the Central Drugs Standard Control Organization (CDSCO) / Drugs Controller General of India (DCGI).
• Cartagena Protocol on Biosafety: Ratified by India in 2003, this international treaty under the Convention on Biological Diversity (CBD) guides transboundary movement and risk assessment of LMOs.

Six Competent Authorities under Rules, 1989

The Rules, 1989 establish six specific regulatory bodies to monitor biotech activities at different administrative and institutional stages.

Institutional Biosafety Committee (IBSC)

Operates at the institute or organization level (universities, laboratories, companies) conducting recombinant DNA research. It acts as the initial point of contact for biosafety compliance and reviews containment practices during preliminary experimental stages.

Review Committee on Genetic Manipulation (RCGM)

Functioning under the Department of Biotechnology (DBT) within the Ministry of Science and Technology, RCGM monitors ongoing research involving hazardous microorganisms and recombinant DNA. It authorizes small-scale contained research, preclinical toxicity studies, and limited experimental field trials.

Genetic Engineering Appraisal Committee (GEAC)

Functioning as the apex statutory body under the Ministry of Environment, Forest and Climate Change (MoEFCC), GEAC is responsible for approving activities involving the large-scale use of hazardous microorganisms and GMOs in research and industrial production. It grants authorization for environmental releases, including commercial cultivation of GM crops and environmental trials.

Recombinant DNA Advisory Committee (RDAC)

An advisory body housed within the Department of Biotechnology (DBT) that reviews developments in biotechnology nationally and internationally. It formulates safety guidelines for recombinant DNA research and periodically updates recommendations for safe laboratory practices.

State Biotechnology Coordination Committee (SBCC)

Operates at the state level under the chairmanship of the State Chief Secretary. It possesses powers to inspect, investigate, and take punitive action against safety violations or unapproved releases of GMOs within the respective state boundaries.

District Level Committee (DLC)

Operates at the district administrative level under the District Collector. It inspects local facilities, monitors compliance, and reports instances of unauthorized GMO activities to the SBCC or GEAC.

Regulatory Hierarchy and Institutional Mapping

Key Exam Facts

• The Environment (Protection) Act, 1986 is the overarching statute under which the Rules, 1989 were framed to govern genetically modified organisms.
• Bt Cotton remains the only genetically modified crop officially approved for commercial cultivation in India (approved by GEAC in 2002).
• In 2010, the GEAC was renamed from “Genetic Engineering Approval Committee” to “Genetic Engineering Appraisal Committee.”
• The Department of Biotechnology (DBT) exempts certain categories of genome-edited plants—specifically SDN-1 (Site-Directed Nuclease-1) and SDN-2—from strict GMO regulations under Rules 1989, treating them differently from transgenic SDN-3 edits.
• India signed the Cartagena Protocol on Biosafety on January 23, 2003, committing to global standards for safe transfer, handling, and use of living modified organisms.
• The Biotechnology Regulatory Authority of India (BRAI) Bill was proposed in 2013 to establish a unified, single-window regulator, replacing the multi-agency system, but the bill lapsed.